Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (111-120 of 288) with videos related to

Pageof 29
Sort By:
The Journal of Rheumatology|February 16, 2022
Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Kristina Callis Duffin, Dafna D Gladman, Niti Goel, et al.
Arthritis and Rheumatism|March 27, 2013
Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active diseaseLaura C Coates, Oliver FitzGerald, Dafna D Gladman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohortRoisin Adams, Benjamin M Craig, Cathal D Walsh, et al.
The Journal of Rheumatology|April 2, 2022
Basic Science Session 1. Biomarkers for Psoriatic Arthritis Treatment Response and Joint Damage Progression: An Update on 2 Industry-GRAPPA ProjectsJames C Waddington, Orla Coleman, Philip J Mease, et al.
Arthritis and Rheumatism|June 10, 2004
Increased synovial tissue NF-kappa B1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritisMaria J Benito, Eithne Murphy, Evelyn P Murphy, et al.
Rheumatology International|May 2, 2020
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritisPhilip J Mease, Iain B McInnes, Vibeke Strand, et al.
The Journal of Rheumatology|March 3, 2019
Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or AdalimumabDésirée van der Heijde, Dafna D Gladman, Oliver FitzGerald, et al.
Neurology|September 11, 2020
Update: Atypical presentation of a midgut neuroendocrine tumor originally diagnosed as eosinophilic fasciitisLoai A Shakerdi, Aadil Al Ghafri, Niall Swan, et al.
Journal of the American Academy of Dermatology|May 23, 2006
Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapyTrevor Markham, Ronan Mullan, Lucy Golden-Mason, et al.
Proteomics. Clinical Applications|September 3, 2015
Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discoveryAngela McArdle, Aisha Qasim Butt, Agnes Szentpetery, et al.
Pageof 29

Showing results (111-120 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Rheumatology|February 16, 2022
Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Kristina Callis Duffin, Dafna D Gladman, Niti Goel, et al.
Arthritis and Rheumatism|March 27, 2013
Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active diseaseLaura C Coates, Oliver FitzGerald, Dafna D Gladman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohortRoisin Adams, Benjamin M Craig, Cathal D Walsh, et al.
The Journal of Rheumatology|April 2, 2022
Basic Science Session 1. Biomarkers for Psoriatic Arthritis Treatment Response and Joint Damage Progression: An Update on 2 Industry-GRAPPA ProjectsJames C Waddington, Orla Coleman, Philip J Mease, et al.
Arthritis and Rheumatism|June 10, 2004
Increased synovial tissue NF-kappa B1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritisMaria J Benito, Eithne Murphy, Evelyn P Murphy, et al.
Rheumatology International|May 2, 2020
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritisPhilip J Mease, Iain B McInnes, Vibeke Strand, et al.
The Journal of Rheumatology|March 3, 2019
Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or AdalimumabDésirée van der Heijde, Dafna D Gladman, Oliver FitzGerald, et al.
Neurology|September 11, 2020
Update: Atypical presentation of a midgut neuroendocrine tumor originally diagnosed as eosinophilic fasciitisLoai A Shakerdi, Aadil Al Ghafri, Niall Swan, et al.
Journal of the American Academy of Dermatology|May 23, 2006
Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapyTrevor Markham, Ronan Mullan, Lucy Golden-Mason, et al.
Proteomics. Clinical Applications|September 3, 2015
Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discoveryAngela McArdle, Aisha Qasim Butt, Agnes Szentpetery, et al.
Pageof 29